risperidone has been researched along with 2019 Novel Coronavirus Disease in 5 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A retrospective self-controlled study was conducted on 90 patients with schizophrenia from a single-center treated with olanzapine or clozapine monotherapy, or combined with aripiprazole or ziprasidone which has a small metabolic impact." | 8.02 | The effect of prohibiting outside food during COVID-19 pandemic on the body weight of schizophrenic patients taking olanzapine or clozapine: a retrospective self-controlled study. ( Ding, W; Hu, C; Hu, M; Li, H; Sun, X; Wang, Q; Wang, X; Wu, M; Zhang, C, 2021) |
| "A retrospective self-controlled study was conducted on 90 patients with schizophrenia from a single-center treated with olanzapine or clozapine monotherapy, or combined with aripiprazole or ziprasidone which has a small metabolic impact." | 4.02 | The effect of prohibiting outside food during COVID-19 pandemic on the body weight of schizophrenic patients taking olanzapine or clozapine: a retrospective self-controlled study. ( Ding, W; Hu, C; Hu, M; Li, H; Sun, X; Wang, Q; Wang, X; Wu, M; Zhang, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prokopez, CR | 1 |
| Farinola, R | 1 |
| Vallejos, M | 1 |
| Lopredo, LS | 1 |
| Sfriso, LE | 1 |
| Chiapella, LC | 1 |
| Arce, C | 1 |
| Corral, RM | 1 |
| Cuesta, MJ | 1 |
| Alomo, M | 1 |
| Dhir, S | 1 |
| Khalid, Z | 1 |
| Salcedo, J | 1 |
| Shanbour, A | 1 |
| Haddad, PM | 1 |
| Al Abdulla, M | 1 |
| Latoo, J | 1 |
| Iqbal, Y | 1 |
| Parker, C | 1 |
| Slan, A | 1 |
| Shalev, D | 1 |
| Critchfield, A | 1 |
| Zhang, C | 1 |
| Wang, X | 1 |
| Hu, C | 1 |
| Ding, W | 1 |
| Li, H | 1 |
| Wu, M | 1 |
| Hu, M | 1 |
| Wang, Q | 1 |
| Sun, X | 1 |
5 other studies available for risperidone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
Topics: Antipsychotic Agents; Benzodiazepines; COVID-19; Humans; Olanzapine; Quetiapine Fumarate; Risperidon | 2022 |
Acetyl-l-Carnitine and New-Onset Psychosis During the COVID-19 Pandemic.
Topics: Acetylcarnitine; Antipsychotic Agents; COVID-19; Delusions; Dietary Supplements; Humans; Male; Middl | 2020 |
Brief psychotic disorder associated with quarantine and mild COVID-19.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; COVID-19; Humans; Lorazepam; Ma | 2020 |
Abrupt Late-onset Psychosis as a Presentation of Coronavirus 2019 Disease (COVID-19): A Longitudinal Case Report.
Topics: Acute Disease; Antipsychotic Agents; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Longitudinal S | 2021 |
The effect of prohibiting outside food during COVID-19 pandemic on the body weight of schizophrenic patients taking olanzapine or clozapine: a retrospective self-controlled study.
Topics: Antipsychotic Agents; Benzodiazepines; Body Weight; China; Clozapine; COVID-19; Humans; Olanzapine; | 2021 |